REATA PHARMACEUTICALS INC-A (RETA) Earnings History & Surprises
NASDAQ:RETA • US75615P1030
172.36 USD
+0.04 (+0.02%)
At close: Sep 25, 2023
172.4 USD
+0.04 (+0.02%)
After Hours: 9/25/2023, 8:12:09 PM
Past quarterly earnings results for REATA PHARMACEUTICALS INC-A (RETA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateNov 6, 2023
PeriodQ3 / 2023
EPS Estimate-$2.13
Revenue Estimate29.575M
Last Reported
Release DateAug 8, 2023
PeriodQ2 / 2023
EPS Reported$4.65
EPS Surprise 258.50%
Revenue Surprise 18,718.57%
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | 4.65 | -2.93 | 258.50% | 330.20% | 22.746M | 120.87K | 18,718.57% | 2,885.04% |
| Q1 2023 | -3.14 | -2.47 | -27.16% | -54.68% | 195K | 161.415K | 20.81% | -78.67% |
| Q4 2022 | -2.33 | -2.25 | -3.37% | 0.85% | 501.259K | -100.00% | -100.00% | |
| Q3 2022 | -2.16 | -2.23 | 2.92% | -9.64% | 540K | 658.155K | -17.95% | -92.69% |
| Q2 2022 | -2.02 | -2.06 | 2.03% | -1.00% | 762K | 1.487M | -48.76% | -65.69% |
| Q1 2022 | -2.03 | -2.22 | 8.37% | -9.14% | 914K | 1.584M | -42.30% | -2.77% |
| Q4 2021 | -2.35 | -2.35 | 0.17% | -23.68% | 933K | 1.659M | -43.76% | -70.75% |
| Q3 2021 | -1.97 | -2.21 | 10.79% | -1.55% | 7.391M | 2.116M | 249.29% | 427.93% |
| Q2 2021 | -2.00 | -2.10 | 4.66% | -19.76% | 2.221M | 1.274M | 74.33% | -27.65% |
| Q1 2021 | -1.86 | -2.14 | 13.03% | -26.53% | 940K | 1.212M | -22.44% | -30.37% |
| Q4 2020 | -1.90 | -2.20 | 13.60% | - | 3.19M | 1.474M | 116.42% | - |
| Q3 2020 | -1.94 | -2.02 | 3.86% | - | 1.4M | 1.301M | 7.61% | - |
| Q2 2020 | -1.67 | -2.89 | 42.29% | - | 3.07M | 1.064M | 188.53% | - |
| Q1 2020 | -1.47 | -2.02 | 27.09% | - | 1.35M | 2.083M | -35.19% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
57.72%
Max EPS beat (4)
258.50%
Min EPS beat (4)
-27.16%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
4,655.35%
Max Revenue beat (4)
18,718.60%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, RETA has beaten EPS estimates in 2 out of 4 releases
RETA has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, RETA has beaten the EPS estimates by 57.7% on average.
In the last 4 quarters, RETA has beaten the revenue estimates by 4655.4% on average.
REATA PHARMACEUTICALS INC-A / RETA Earnings FAQ
What is the most recent earnings date for RETA stock?
REATA PHARMACEUTICALS INC-A (RETA) last reported earnings on 8/8/2023.
Can you provide information on whether REATA PHARMACEUTICALS INC-A beat earnings estimates in the last quarter?
REATA PHARMACEUTICALS INC-A (RETA) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does RETA stock beat earnings estimates?
In the last 4 quarters, REATA PHARMACEUTICALS INC-A (RETA) has beaten EPS estimates in 2 out of 4 releases.